Articles
-
Jan 2, 2025 |
mdpi.com | Bei Li
1. IntroductionMN technology has emerged as a method capable of penetrating the stratum corneum and reaching the epidermis without affecting the nerve endings in the dermis. This technology offers a painless, convenient, and highly effective alternative for applications such as cosmetic enhancement, transdermal drug delivery, and monitoring. During the global COVID-19 pandemic, MN technology had advantages such as the absence of expensive equipment or extensive training.
-
Oct 23, 2024 |
dx.doi.org | Min Lv |Xiangxiang Zhang |Bei Li |Baibiao Huang
-
Sep 7, 2024 |
mdpi.com | Bei Li |Sheng Jiao |Yuan Zhou |Min Zhou
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Jul 1, 2024 |
nature.com | Bei Li
AbstractGastric cancer (GC) is the 5th most prevalent cancer and the 4th primary cancer-associated mortality globally. As the first identified m6A demethylase for removing RNA methylation modification, fat mass and obesity-associated protein (FTO) plays instrumental roles in cancer development. Therefore, we study the biological functions and oncogenic mechanisms of FTO in GC tumorigenesis and progression. In our study, FTO expression is obviously upregulated in GC tissues and cells.
-
May 21, 2024 |
onlinelibrary.wiley.com | Jie Liu |Nanotechnology The |Bei Li |Xin Ming
1 Introduction Chemotherapy remains the mainstay of cancer treatment even in the era of immunotherapy, including immune checkpoint blockade (ICB) and adoptive T-cell therapy.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →